Cargando…
Lung cancer screening: from imaging to biomarker
Despite several decades of intensive effort to improve the imaging techniques for lung cancer diagnosis and treatment, primary lung cancer is still the number one cause of cancer death in the United States and worldwide. The major causes of this high mortality rate are distant metastasis evident at...
Autores principales: | Xiang, Dong, Zhang, Bicheng, Doll, Donald, Shen, Kui, Kloecker, Goetz, Freter, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776246/ https://www.ncbi.nlm.nih.gov/pubmed/24252206 http://dx.doi.org/10.1186/2050-7771-1-4 |
Ejemplares similares
-
Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
por: Bhandari, Shruti, et al.
Publicado: (2021) -
Cellular Therapy for Lung Cancer: Focusing on Chimeric Antigen Receptor T (CAR T) Cells and Tumor-Infiltrating Lymphocyte (TIL) Therapy
por: Katiyar, Vatsala, et al.
Publicado: (2023) -
Classification of biosensor time series using dynamic time warping: applications in screening cancer cells with characteristic biomarkers
por: Rai, Shesh N, et al.
Publicado: (2016) -
Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond
por: Kanaan, Zeyad, et al.
Publicado: (2015) -
Lipid Metabolism, Apoptosis and Cancer Therapy
por: Huang, Chunfa, et al.
Publicado: (2015)